A phase III study assessing IMG-002
Latest Information Update: 19 Feb 2021
Price :
$35 *
At a glance
- Drugs IMG-002 (Primary)
- Indications Autoimmune disorders
- Focus Therapeutic Use
- 19 Feb 2021 New trial record
Latest Information Update: 19 Feb 2021